Department of Medicine, St. Luke's Hospital, Chesterfield, Missouri, USA.
Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
J Viral Hepat. 2020 Oct;27(10):1022-1031. doi: 10.1111/jvh.13320. Epub 2020 Jun 9.
Liver fibrosis may be assessed noninvasively with transient electrography (TE). Data on the performance of TE for detecting liver fibrosis in sub-Saharan Africa are limited. We evaluated the diagnostic accuracy of TE by performing liver biopsies on persons with liver fibrosis indicated by TE. We enrolled HIV-infected and HIV-uninfected participants with TE scores consistent with at least minimal disease (liver stiffness measurement [LSM]≥7.1 kPa). Biopsies were performed and staged using the Ishak scoring system. A concordant result was defined using accepted thresholds for significant fibrosis by TE (LSM ≥ 9.3 kPa) and liver biopsy (Ishak score ≥ 2). We used modified Poisson regression methods to quantify the univariate and adjusted prevalence risk ratios (PRR) of the association between covariates and the concordance status of TE and liver biopsy in defining the presence of liver fibrosis. Of 131 participants with valid liver biopsy and TE data, only 5 participants (3.8%) had Ishak score ≥ 2 of whom 4 had LSM ≥ 9.3 kPa (sensitivity = 80%); of the 126 (96.2%) with Ishak score < 2, 76 had LSM < 9.3 kPa (specificity = 61%). In multivariable analysis, discordance was associated with female gender (adjPRR = 1.80, 95%CI 1.1-2.9; P = .019), herbal medicine use (adjPRR 1.64, 95% CI = 1.0-2.5; P = .022), exposure to lake or river water (adjPRR 2.05, 95% CI = 1.1-3.7; P = .016), and current smoking (adjPRR 1.72, 95%CI 1.0-2.9; P = .045). These data suggest that TE among rural Ugandans has low specificity for detection of histologically confirmed liver fibrosis. Caution should be exercised when using this tool to confirm significant liver fibrosis.
肝纤维化可以通过瞬时电描记术(TE)进行非侵入性评估。关于 TE 在撒哈拉以南非洲地区检测肝纤维化的性能的数据有限。我们通过对 TE 提示肝纤维化的患者进行肝活检来评估 TE 的诊断准确性。我们招募了 HIV 感染和未感染的患者,他们的 TE 评分符合至少最低疾病(肝硬度测量[LSM]≥7.1kPa)。进行了活检,并使用 Ishak 评分系统进行分期。使用 TE(LSM≥9.3kPa)和肝活检(Ishak 评分≥2)的公认显著纤维化阈值来定义一致结果。使用修正泊松回归方法来量化协变量与 TE 和肝活检的一致性状态之间的关联的单变量和调整后的患病率风险比(PRR),以定义肝纤维化的存在。在 131 名具有有效肝活检和 TE 数据的参与者中,只有 5 名(3.8%)参与者的 Ishak 评分≥2,其中 4 名的 LSM≥9.3kPa(敏感性=80%);在 126 名(96.2%)Ishak 评分<2 的患者中,76 名的 LSM<9.3kPa(特异性=61%)。在多变量分析中,不一致与女性(adjPRR=1.80,95%CI 1.1-2.9;P=0.019)、草药使用(adjPRR 1.64,95%CI=1.0-2.5;P=0.022)、接触湖水或河水(adjPRR 2.05,95%CI=1.1-3.7;P=0.016)和当前吸烟(adjPRR 1.72,95%CI=1.0-2.9;P=0.045)有关。这些数据表明,在乌干达农村地区,TE 对组织学证实的肝纤维化的检测特异性较低。在使用该工具确认显著肝纤维化时应谨慎。